Pfizer Covid-19 vaccine poised to get full FDA approval next week
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[WASHINGTON] The US Food and Drug Administration (FDA) is poised to fully approve Pfizer's coronavirus vaccine early next week as US President Joe Biden's administration tries to woo more Americans to get the shot.
The approval likely will come on Monday or Tuesday, according to one official familiar with the plans, speaking on condition of anonymity ahead of the announcement.
Pfizer's vaccine has been in use in the US based on an emergency authorisation. The White House referred questions to the FDA, which didn't immediately respond to requests for comment. The development was first reported by Politico.
Mr Biden has called for approval. He believes it will ease doubts about the vaccine and also give firmer footing for companies and schools to require inoculations, officials familiar with his thinking say.
"My plea is that for those who are not vaccinated: Think about it," Mr Biden said earlier this month. "God willing, the FDA is going to be coming out in a reasonable timeframe to say this vaccine is totally safe."
Mr Biden has yet to nominate a permanent head of the FDA. The administration has privately decided against nominating the acting commissioner, Janet Woodcock, people familiar with the plans have said.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
BLOOMBERG
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services